Imatinib spells BAD news for Bcr/abl-positive leukemias
- PMID: 17003111
- PMCID: PMC1595406
- DOI: 10.1073/pnas.0607135103
Imatinib spells BAD news for Bcr/abl-positive leukemias
Conflict of interest statement
The author declares no conflict of interest.
Figures
Comment on
-
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14907-12. doi: 10.1073/pnas.0606176103. Epub 2006 Sep 22. Proc Natl Acad Sci U S A. 2006. PMID: 16997913 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
